[Skip to Navigation]
[Skip to Navigation Landing]
Article
November 1943

PROSTIGMINE THERAPY OF ATROPHIC RHINITIS

Author Affiliations

MEDICAL CORPS, ARMY OF THE UNITED STATES; CHICAGO
From the Illinois Eye and Ear Infirmary.

Arch Otolaryngol. 1943;38(5):426-432. doi:10.1001/archotol.1943.00670040445002
Abstract

Recent literature has pointed to new trends in the treatment of atrophic rhinitis. Soskin and Bernheimer1 have pointed out that the good results reported with the use of estrogenic substances in the treatment of atrophic rhinitis were due to the secondary hyperemia associated with direct nasal application of estrogens. They expressed the belief that the primary hormonal effects were not the essential factor and used prostigmine methylsulfate successfully to produce a prolonged hyperemia in patients with atrophic rhinitis. Whether the pathologic change of atrophic rhinitis is primary, as the so-called ozena, or secondary in type, resulting from infection, the atrophy is dependent on limitation of the blood supply. The other changes, such as mucoid degeneration of the epithelium with later squamification, periglandular lymphocytic infiltration, glandular proliferation and diminution in volume of tissue, are directly and indirectly related to the local changes in blood volume. In ozena the obliterative endarteritis brings

×